Summary:
The study is available to healthy male volunteers.
This study involves a drug which is developed for the treatment of chronic obstructive pulmonary disease (COPD) (where patients will experience breathing problems and poor airflow), and a drug called which is an antifungal medication used for the treatment of oropharyngeal and esophageal candidiasis (fungal infection of the mouth and/or throat).
Qualified Participants Must:
• Being healthy
•
Be a male
•
Be a non-smoker
•
Be aged between 18 and 65 years old
•
Have a BMI between 18 to 30